NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma

por Miftah, Hayat, Naji, Oumayma, Ssi, Saadia Ait, Ghouzlani, Amina, Lakhdar, Abdelhakim, Badou, Abdallah
Publicado 2023